Letter from the Vice President Corporate
Affairs, Philip Morris European Union Region, to the Clerk of
the Committee (TB 19A)
I am responding to your letter of 14 January
2000 asking for written supplementary evidence from Philip Morris
Europe SA ("Philip Morris") to the inquiry of the Health
Committee into the tobacco industry and the health risks of smoking.
Philip Morris is gathering the information necessary
to provide the Commitee with the financial data referred to in
your first question. The response will be provided on behalf of
all affiliates of Philip Morris and we have not completed the
effort to gather all of the necessary information. We will provide
a response to this inquiry prior to the further hearing scheduled
for 27 January 2000. As those Members of the Committee who met
with us in Washington DC are aware, Philip Morris has devoted
significant resources to research and development. Philip Morris's
research and development budget for Accord, the new product that
was shown to the Committee members in Washington, was 245.9 million
US dollars from 1990 to 1998. In addition, the Committee is aware
of Philip Morris' development of a denicotinized cigarette. From
1987 through 1991, Philip Morris spent approximately 300 million
US dollars on the research and development budget for its denicotinized
cigarettes.
In relation to your second question I can confirm
that neither Philip Morris SA nor any affiliate of Philip Morris
was a party to litigation proceedings brought by certain tobacco
companies in relation to the activities of the SCOTH Committee.
You have asked whether Philip Morris believes
that nicotine is addictive by reference to either of the DSM-IV
or ICD 10 criteria. DSM-IV (the "American Diagnostic and
Statistical Manual" (1994)) and ICD-10 ("International
Statistical Classification of Diseases and Related Health Problems
Tenth Revision", World Health Organization, 1992) respectively
use the terms "substance dependence" and "dependency
syndrome" rather than addiction. We recognize that under
the definition of "substance dependence" set forth in
the DSM-IV cigarette smoking is a "substance dependence".
Equally we acknowledge that in the IDC-10 smoking is considered
a "dependence syndrome". Indeed, we have stated in our
web site that "the World Health Organization has classified
smoking as an addiction."
Philip Morris does not wish to, and will not
take issue with these messages. We believe that it is important
that smokers and nonsmokers alike hear a single, consistent message
on the issue of smoking and addiction, and we will not engage
in a debate over the message provided by the public health authorities
on this issue. Consistent with this principle, we will not debate
the application of the criteria in the IDC-10 and the DSM-IV to
smoking. As we stated in our submission to the Committee and in
our Web Site (www.philipmorris.com), cigarette smoking is addictive
as that term is most commonly used today. In my testimony before
the Committee on 13 January 2000 I stated our view that cigarette
smoking is addictive by most definitions commonly used today.
You have also asked a number of questions in
relation to smoking and certain diseases. Philip Morris believes
that its views in relation to each of these questions were provided
in its submission to the Committee. Further I stated our views
in relation to these issues in my testimony on 13 January 2000.
Our position is that there is an overwhelming medical and scientific
consensus that cigarette smoking causes lung cancer, heart disease,
emphysema and other serious diseases in smokers. Further, we have
stated in our web site that "smokers are far more likely
to develop serious diseases, like lung cancer, than non-smokers.
There is no safe cigarette. These are and have been the messages
of the public health authorities worldwide. Smokers and potential
smokers should rely on these messages in making all smoking-related
decisions."
We believe that it is important that smokers
and nonsmokers alike hear a single, consistent message on the
issue of smoking and disease, and we will not engage in a debate
over the message provided by the public health authorities on
this issue. We believe it appropriate that public policy and regulation
should be guided and controlled by these views. We therefore concur
that from a public health perspective smoking causes disease in
smokers.
20 January 2000
|